SBPLX
Price
$30.46
Change
+$0.02 (+0.07%)
Updated
Aug 15 closing price
Net Assets
8.78B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

SBPLX vs VVIAX

Header iconSBPLX vs VVIAX Comparison
Open Charts SBPLX vs VVIAXBanner chart's image
ClearBridge Dividend Strategy C
Price$30.46
Change+$0.02 (+0.07%)
VolumeN/A
Net Assets8.78B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
SBPLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SBPLX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBPLX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. SBPLX (8.78B). VVIAX pays higher dividends than SBPLX: VVIAX (2.18) vs SBPLX (0.53). SBPLX was incepted earlier than VVIAX: SBPLX (27 years) vs VVIAX (25 years). SBPLX (1.74) is less costly to investors than VVIAX (0.05). SBPLX is a more actively managed with annual turnover of: 19.00 vs. VVIAX (9.00). SBPLX has a lower initial minimum investment than VVIAX: SBPLX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. SBPLX (3.25). VVIAX return over 5 years is better than : 68.54 vs. SBPLX (28.58).
SBPLXVVIAXSBPLX / VVIAX
Total Expense Ratio1.740.053,480%
Annual Report Gross Expense Ratio1.740.053,480%
Fund Existence27 years25 years-
Gain YTD5.3366.51782%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets8.78B196B4%
Annual Yield % from dividends0.532.1824%
Returns for 1 year3.257.9141%
Returns for 3 years8.2725.9332%
Returns for 5 years28.5868.5442%
Returns for 10 years64.39114.6156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp